Editorial Comment

      This series adds to a growing body of literature that demonstrates that robot-assisted radical cystectomy (RARC) with extracorporeal urinary diversion and complete pelvic lymph node dissection can be performed by experienced surgeons with acceptable outcomes. Although this is a single surgeon series, it is robust in terms of numbers (N = 175), median follow-up (37 months), use of neoadjuvant chemotherapy (22%), and the consecutive nature of patient inclusion helping to mitigate the selection bias that detracts from most nonrandomized series. The results suggest, as other studies have also shown, a general noninferiority of RARC when compared with open radical cystectomy (ORC).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Linked Article